{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:49:21Z","timestamp":1787237361378,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T00:00:00Z","timestamp":1577318400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T00:00:00Z","timestamp":1577318400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1208\/s12249-019-1587-5","type":"journal-article","created":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T12:02:37Z","timestamp":1577361757000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Systematic Optimization, In Vitro Drug Release, and Preliminary Nonclinical Toxicity Assessment of Nonphospholipid-Based Topical Ophthalmic Emulsions Containing 0.05 or 0.1% w\/w Cyclosporin A for Dry-Eye Syndrome Management"],"prefix":"10.1208","volume":"21","author":[{"given":"Syed Nazrin Ruhina","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Datta Maroti","family":"Pawde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oly","family":"Katari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Hmingthansanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7338-3207","authenticated-orcid":false,"given":"Tamilvanan","family":"Shunmugaperumal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,26]]},"reference":[{"key":"1587_CR1","unstructured":". Q8(R2) pharmaceutical development. Part I: pharmaceutical development, and Part II: annex to pharmaceutical development. http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Quality\/Q8_R1\/Step4\/Q8_R2_Guideline.pdf (2009). Accessed date 1 Aug 2019."},{"key":"1587_CR2","unstructured":"ICH. Q9 quality risk management. http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Quality\/Q9\/Step4\/Q9_Guideline.pdf (2005). Accessed date1 Aug 2019."},{"key":"1587_CR3","unstructured":"ICH. Q10 pharmaceutical quality system. http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Quality\/Q10\/Step4\/Q10_Guideline.pdf (2008). Accessed date 1 Aug 2019."},{"key":"1587_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ajo.2003.10.036","volume":"137","author":"SC Pflugfelder","year":"2004","unstructured":"Pflugfelder SC. Antiinflammatory therapy for dry eye. Am J Ophthalmol. 2004;137:337\u201342.","journal-title":"Am J Ophthalmol"},{"key":"1587_CR5","doi-asserted-by":"publisher","first-page":"3686","DOI":"10.1073\/pnas.89.9.3686","volume":"89","author":"DA Fruman","year":"1992","unstructured":"Fruman DA, Klee CB, Bierer BE, Burakoff SJ. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc Natl Acad Sci U S A. 1992;89:3686\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1587_CR6","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","volume":"15","author":"AJ Bron","year":"2017","unstructured":"Bron AJ, de Paiva CS, Chauhan SK, Bonini S, Gabison EE, Jain S, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017;15:438\u2013510. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.011.","journal-title":"Ocul Surf"},{"issue":"4","key":"1587_CR7","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1208\/s12249-012-9844-x","volume":"13","author":"R Fahmy","year":"2012","unstructured":"Fahmy R, Kona R, Dandu R, Xie W, Claycamp G, Hoag SW. Quality by design I: application of failure mode effect analysis (FMEA) and Plackett-Burman design of experiments in the identification of \u201cmain factors\u201d in the formulation and process design space for roller-compacted ciprofloxacin hydrochloride immediate-release tablets. AAPS PharmSciTech. 2012;13(4):1243\u201354. https:\/\/doi.org\/10.1208\/s12249-012-9844-x.","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"1587_CR8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3109\/02652048.2015.1046513","volume":"32","author":"P Negi","year":"2015","unstructured":"Negi P, Singh B, Sharma G, Beg S, Katare OP. Biocompatible lidocaine and prilocaine loaded-nanosized emulsion system for enhanced percutaneous absorption: QbD-based optimisation, dermatokinetics and in vivo evaluation. J Microencapsul. 2015;32(5):419\u201331. https:\/\/doi.org\/10.3109\/02652048.2015.1046513.","journal-title":"J Microencapsul"},{"issue":"1","key":"1587_CR9","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1080\/10717544.2018.1458923","volume":"25","author":"Y Yu","year":"2018","unstructured":"Yu Y, Chen D, Li Y, Yang W, Tu J, Shen Y. Improving the topical ocular pharmacokinetics of lyophilized cyclosporine A loaded micelles: formulation, in vitro and in vivo studies. Drug Delivery. 2018;25(1):888\u201399. https:\/\/doi.org\/10.1080\/10717544.2018.1458923.","journal-title":"Drug Delivery"},{"key":"1587_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ijpharm.2006.05.060","volume":"323","author":"LX Wang","year":"2006","unstructured":"Wang LX, He HB, Tang X, Shao RY, Chen DW. A less irritant norcantharidin lipid microsphere: formulation and drug distribution. Int J Pharm. 2006;323:161\u20137.","journal-title":"Int J Pharm"},{"key":"1587_CR11","unstructured":"Moses RA. Adler\u2019s physiology of the eye clinical application. St. Louis, MO: The C.V. Mosby Company (1981) 16-23."},{"issue":"9","key":"1587_CR12","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3109\/03639045.2011.555407","volume":"37","author":"S Tamilvanan","year":"2011","unstructured":"Tamilvanan S, Kumar BA. Influence of acetazolamide loading on the (in vitro) performances of non-phospholipid-based cationic nanosized emulsion in comparison with phospholipid-based anionic and neutral-charged nanosized emulsions. Drug Dev Ind Pharm. 2011;37(9):1003\u201315. https:\/\/doi.org\/10.3109\/03639045.2011.555407.","journal-title":"Drug Dev Ind Pharm"},{"key":"1587_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.chemphyslip.2004.04.003","volume":"131","author":"L Rabinovich-Guilatt","year":"2004","unstructured":"Rabinovich-Guilatt L, Couvreur P, Lambert G, Goldstein D, Benita S, Dubernet C. Extensive surface studies help to analyse zeta potential data: the case of cationic emulsions. Chem Phys Lipids. 2004;131:1\u201313.","journal-title":"Chem Phys Lipids"},{"key":"1587_CR14","first-page":"421","volume":"11","author":"S Tamilvanan","year":"2001","unstructured":"Tamilvanan S, Khoury K, Gilhar D, Benita S. Ocular delivery of cyclosporin A. I. Design and characterization of cyclosporin A-loaded positively-charged submicron emulsion. STP Pharm Sci. 2001;11:421\u20136.","journal-title":"STP Pharm Sci"},{"key":"1587_CR15","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1208\/s12249-010-9455-3","volume":"11","author":"S Tamilvanan","year":"2010","unstructured":"Tamilvanan S, Kumar BA, Senthilkumar SR, Baskar R, Sekharan TR. Stability assessment of injectable castor oil-based nano-sized emulsion containing cationic droplets stabilized by poloxamer-chitosan emulsifier films. AAPS PharmSciTech. 2010;11:904\u20139.","journal-title":"AAPS PharmSciTech"},{"key":"1587_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ejpb.2009.06.002","volume":"73","author":"CM Woitiski","year":"2009","unstructured":"Woitiski CM, Veiga F, Ribiero A, Neufeld R. Design for optimization of nanoparticles integrating biomaterials for orally dose insulin. Eur J Pharm Biopharm. 2009;73:25\u201333.","journal-title":"Eur J Pharm Biopharm"},{"key":"1587_CR17","first-page":"513","volume":"68","author":"SK Motwani","year":"2008","unstructured":"Motwani SK, Copra S, Talegaonkar S, Kohli K, Ahmad FJ, Khar RK. Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimization and in vitro characterization. J Pharmacokinet Biopharm. 2008;68:513\u201325.","journal-title":"J Pharmacokinet Biopharm"},{"key":"1587_CR18","first-page":"857","volume":"32","author":"AT Joglekar","year":"1987","unstructured":"Joglekar AT. Product excellence through design of experiments. Cereal Foods World. 1987;32:857\u201368.","journal-title":"Cereal Foods World"},{"key":"1587_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0378-5173(97)00369-4","volume":"163","author":"M Jumaa","year":"1998","unstructured":"Jumaa M, M\u00fcller BW. The effect of oil components and homogenization conditions on the physicochemical properties and stability of parenteral fat emulsions. Int J Pharm. 1998;163:81\u20139.","journal-title":"Int J Pharm"},{"key":"1587_CR20","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ultsonch.2011.07.001","volume":"19","author":"SY Tang","year":"2012","unstructured":"Tang SY, Manickam S, Wei TK, Nashiru B. Formulation development and optimization of a novel Cremophor EL-based nanoemulsion using ultrasound cavitation. Ultrason Sonochem. 2012;19:330\u201345.","journal-title":"Ultrason Sonochem"},{"key":"1587_CR21","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ejps.2004.04.003","volume":"22","author":"M Cegnar","year":"2004","unstructured":"Cegnar M, Kos J, Kristl J. Cystatin incorporated in poly(lactide-co-glycolide) nanoparticles: development and fundamental studies on preservation of its activity. Eur J Pharm Sci. 2004;22:357\u201364.","journal-title":"Eur J Pharm Sci"},{"key":"1587_CR22","volume-title":"Colloidal carriers for controlled drug delivery and targeting: modification, characterization and in vivo distribution","author":"RH M\u00fcllar","year":"1990","unstructured":"M\u00fcllar RH. Colloidal carriers for controlled drug delivery and targeting: modification, characterization and in vivo distribution. Wiss Verl-Ges: Stuttgart, Germany; 1990."},{"key":"1587_CR23","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ijpharm.2009.08.001","volume":"381","author":"S Tamilvanan","year":"2009","unstructured":"Tamilvanan S. Formulation of multifunctional oil-in-water nanosized emulsions for active and passive targeting of drugs to otherwise inaccessible internal organs of the human body. Int J Pharm. 2009;381:62\u201376.","journal-title":"Int J Pharm"},{"key":"1587_CR24","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ejpb.2008.03.005","volume":"70","author":"T Hagigit","year":"2008","unstructured":"Hagigit T, Nassar T, Behar-Cohen F, Lambert G, Benita S. The influence of cationic lipid type on in-vitro release kinetic profiles of antisense oligonucleotide from cationic nanoemulsions. Eur J Pharm Biopharm. 2008;70:248\u201359.","journal-title":"Eur J Pharm Biopharm"},{"key":"1587_CR25","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/jps.20627","volume":"95","author":"K Amin","year":"2006","unstructured":"Amin K, Dannenfelser R. In vitro hemolysis: guidance for the pharmaceutical scientist. Eur J Pharm Sci. 2006;95:1173\u20136.","journal-title":"Eur J Pharm Sci"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-019-1587-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-019-1587-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-019-1587-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T14:06:46Z","timestamp":1616594806000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-019-1587-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,26]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1587"],"URL":"https:\/\/doi.org\/10.1208\/s12249-019-1587-5","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,26]]},"assertion":[{"value":"9 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The experimental procedure of the hemolysis test was approved by the Ethics Review Committee of Guwahati Neurological Research Center (GNRC) Hospital, Guwahati, Assam, India.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"36"}}